par Bolla, M.;Van Poppel, H;Collette, Laurence;Van Cangh, Paul Jacques;Vekemans, Kris;Da Pozzo, Luigi;De Reijke, Theo M.;Verbaeys, Antony;Bosset, Jean François;Van Velthoven, Roland
;Maréchal, Jean-Marie;Scalliet, Pierre;Haustermans, Karin;Pierart, Marianne;European Organization for Research and Treatment of Cancer,
Référence Lancet, 366, 9485, page (572-578)
Publication Publié, 2005

Référence Lancet, 366, 9485, page (572-578)
Publication Publié, 2005
Article révisé par les pairs
Titre: |
|
Auteur: | Bolla, M.; Van Poppel, H; Collette, Laurence; Van Cangh, Paul Jacques; Vekemans, Kris; Da Pozzo, Luigi; De Reijke, Theo M.; Verbaeys, Antony; Bosset, Jean François; Van Velthoven, Roland; Maréchal, Jean-Marie; Scalliet, Pierre; Haustermans, Karin; Pierart, Marianne; European Organization for Research and Treatment of Cancer, |
Informations sur la publication: | Lancet, 366, 9485, page (572-578) |
Statut de publication: | Publié, 2005 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adenocarcinoma -- mortality -- pathology -- radiotherapy -- surgery |
Aged | |
Combined Modality Therapy | |
Disease Progression | |
Humans | |
Male | |
Middle Aged | |
Prostatectomy | |
Prostatic Neoplasms -- mortality -- pathology -- radiotherapy -- surgery | |
Survival Rate | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
Research Support, U.S. Gov't, P.H.S. | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0140-6736 |
info:doi/10.1016/S0140-6736(05)67101-2 | |
info:pii/S0140-6736(05)67101-2 | |
info:scp/23744493443 | |
info:pmid/16099293 |